Low Density Lipoprotein-Cholesterol Levels Affect Vertebral Fracture Risk in Female Patients with Primary Hyperparathyroidism

Abstract

Although increased arterial sclerosis and dyslipidemia were observed in primary hyperparathyroidism (pHPT) patients in previous studies, it still remains unclear about the relationships between lipid and bone metabolism in pHPT patients, especially about fracture risk. The present study was performed to examine the relationships between lipid metabolism parameters including body composition and bone metabolism in 116 female patients with pHPT and 116 age-matched control subjects. Bone mineral density (BMD) and body composition were measured by dual-energy x-ray absorptiometry. Serum low density lipoprotein (LDL)-cholesterol (Chol) levels were negatively related to only z-score of BMD at femoral neck and serum creatinine levels. Serum levels of LDL-Chol were significantly lower in the group with vertebral fractures in pHPT patients, although body composition parameters were not significantly different. In univariate logistic regression analyses, age, height, BMD at lumbar spine and radius, serum levels of creatinine, total-Chol and LDL-Chol were significantly selected as a predictor of vertebral fractures. LDL-Chol was related to vertebral fractures independently of the other parameters. In conclusion, the present study demonstrated that lower serum LDL-Chol levels were related to vertebral fracture risk independent of renal function, age, body size, bone metabolism parameters and the severity of the disease in pHPT women.

Key words

primary hyperparathyroidism - lipid metabolism - bone mineral density - vertebral fracture - body composition

References

• 1 Bagger YZ, Rasmussen HB, Alexandersen P. et al . Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?.  Osteoporos Int. 2007;  18 505-512
• 2 Bevier WC, Wiswell RA, Pyka G. et al . Relationship of body composition, muscle strength and aerobic capacity to bone mineral density in older men and women.  J Bone Miner Res. 1989;  4 421-432
• 3 Bolland MJ, Grey AB, Gamble GD. et al . Association between primary hyperparathyroidism and increased body weight: a meta-analysis.  J Clin Endocrinol Metab. 2005;  90 1525-1530
• 4 Chen Q, Kaji H, Iu MF. et al . Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects.  J Clin Endocrinol Metab. 2003;  88 4655-4658
• 5 Sennerby U, Farahmand B, Ahlbom A. et al . Cardiovascular diseases and future risk of hip fracture in women.  Osteoporos Int. 2007;  18 1355-1362
• 6 Dempster DW, Cosman F, Parisien M. et al . Anabolic actions of parathyroid hormone on bone.  Endocr Rev. 1993;  14 690-709
• 7 Delfini E, Petramala L, Caliumi C. et al . Circulation leptin and adiponectin levels in patients with primary hyperparathyroidism.  Metabolism. 2007;  56 30-36
• 8 Fallo F, Camporese G, Capitelli E. et al . Ultrasound evaluation of carotide artery in primary hyperparathyroidism.  J Clin Endocrinol Metab. 2003;  88 2096-2099
• 9 Grey AB, Evans MC, Stapleton JP. et al . Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism.  Ann Intern Med. 1994;  121 745-749
• 10 Hagstrom E, Lundgren E, Rastad J. et al . Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening.  Eur J Endocrinol. 2006;  155 33-39
• 11 Hagstrom E, Lundgren E, Lithell H. et al . Normalized dyslipidemia after parathyroidectomy in mild hyperparathyroidism; population-based study over five years.  Clin Endocrinol. 2002;  56 253-260
• 12 Hanson DA, Weis MA, Bollen AM. et al . A specific immunoassay for monitoring human bone rsorption: quantitation of type I collagen cross-linked N-telopeptides in urine.  J Bone Miner Res. 1992;  7 1251-1258
• 13 Kaji H, Nomura R, Yamauchi M. et al . The usefulness of bone metabolic indices for the prediction of changes in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism.  Horm Metab Res. 2006;  38 411-416
• 14 Kaji H, Yamauchi M, Chihara K. et al . The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.  Eur J Endocrinol. 2005;  153 373-378
• 15 Kaji H, Yamauchi M, Chihara K. et al . The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis.  Endocr J. 2006;  53 27-34
• 16 Kenny AM, MacGillivray DC, Pilbeam CC. et al . Fracture incidence in postmenopausal women with primary hyperparathyroidism.  Surgery. 1995;  118 109-114
• 17 Khosla S, Atkinsen EJ, Riggs BL. et al . Relationship between body composition and bone mass in women.  J Bone Miner Res. 1996;  11 857-863
• 18 Khosla S, Melton III LJ, Wermers RA. et al . Primary hyperparathyroidism and risk of fracture: a population-based study.  J Bone Miner Res. 1999;  14 1700-1707
• 19 Kosch M, Hausberg M, Vormbrock K. et al . Studies on flow-mediated vasodilation and intima-media thickness of the branchial artery in patients with primary hyperparathyroidism.  Am J Hypertens. 2000;  13 759-764
• 20 Kumagai S, Kawano S, Atsumi T. et al . Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases.  J Rheumatol. 2005;  32 863-869
• 21 Larsson K, Ljunghall S, Krusemo UB. et al . The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years.  J Intern Med. 1993;  234 585-593
• 22 Mazess RB, Barden HS, Bisek JP. et al . Dual energy X-ray absorptiometry for total-body and regional bone mineral and soft tissue composition.  Am J Clin Nutr. 1990;  51 1167-1175
• 23 Melton III LJ, Atkinsen EJ, O’Fallon WM. et al . Risk of age-related fractures in patients with primary hyperparathyroidism.  Arch Intern Med. 1992;  152 2269-2273
• 24 von Muhlen D, Safii S, Jassal SK. et al . Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study.  Osteoporos Int. 2007;  18 1337-1344
• 25 Nakaoka D, Sugimoto T, Kobayashi T. et al . Prediction of bone mass change after parathyroidictomy in patients with primary hyperparathyroidism.  J Clin Endocrinol Metab. 2000;  85 1901-1907
• 26 Nakaoka D, Sugimoto T, Kaji H. et al . Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.  Osteoporos Int. 2001;  12 548-554
• 27 Nawata H, Soen S, Takayanagi R. et al . Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Socienty for Bone and Mineral Research.  J Bone Miner Metab. 2005;  23 105-109
• 28 Nuzzo V, Tauchmanova L, Fonderico F. et al . Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism.  Eur J Endocrinol. 2002;  147 453-459
• 29 Reid IR, Ames R, Evans MC. et al . Determinants of total body and regional bone mineral density in normal postmenopausal women: a key role for fat mass.  J Clin Endocrinol Metab. 1992;  75 45-51
• 30 Rubin MR, Maurer MS, McMahon DJ. et al . Arterial stiffness in mild primary hyperparathyroidism.  J Clin Endocrinol Metab. 2005;  90 3326-3330
• 31 Smith-Bindman R, Cummings SR, Steiger P. et al . A comparison of morphometric definitions of vertebral fractures.  J Bone Miner Res. 1991;  6 25-34
• 32 Smith JC, Page MD, John R. et al . Augmentation of central arterial pressure in mild primary hyperparathyroidism.  J Clin Endocrinol Metab. 2001;  85 3515-3519
• 33 Sugimoto T, Kaji H, Nakaoka D. et al . Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis.  Eur J Endocrinol. 2002;  147 339-348
• 34 Tanko LB, Christiansen C, Cox DA. et al . Relationship between osteoporosis and cardiovascular disease in postmenopausal women.  J Bone Miner Res. 2005;  20 1912-1920
• 35 Vestergaard P, Mollerup CL, Frokar VG. et al . Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism.  BMJ. 2000;  321 598-602
• 36 Vestergaard P, Mosekilde L. Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism.  BMJ. 2003;  327 530-534
• 37 Wilson RJ, Rao S, Ellis B. et al . Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures.  Ann Intern Med. 1988;  109 959-962
• 38 Yamaguchi T, Sugimoto T, Yano S. et al . Plasma lipids and osteoporosis in postmenopausal women.  Endocr J. 2002;  49 211-217

Correspondence